Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 446, 363 (22 March 2007) | doi:10.1038/446363a; Published online 21 March 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Medical Writer
- Cactus Global
- Mumbai 400053 India
Faculty Positions in Immunology
- Harvard Medical School (HMS), Dana-Farber Cancer Institute (DFCI)
- Boston, MA
In brief
As tension mounts over drug-pricing policy, pharmaceutical company Abbott says it will not be launching seven new drugs in Thailand, including treatments for HIV and bacterial infections. The move follows the country's decision to issue 'compulsory licences' that allow it to make or import cheap versions of several patented drugs.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Human therapeutic proteins from silkwormsNature Biotechnology Research News (01 Jan 2003)
